ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Research Topic : Therapeutic commitment
Australian State/Territory : NSW
Field of Research : Medical Biotechnology
Clear All
Filter by Field of Research
Medical Biotechnology (2)
Animal Protection (Pests And Pathogens) (1)
Gene Therapy (1)
Therapies And Therapeutic Technology (1)
Filter by Socio-Economic Objective
Infectious diseases (1)
Prevention—biologicals (e.g. vaccines) (1)
Filter by Funding Provider
Australian Research Council (1)
National Health and Medical Research Council (1)
Filter by Status
Closed (2)
Filter by Scheme
Linkage Projects (1)
NHMRC Project Grants (1)
Filter by Country
Australia (2)
Filter by Australian State/Territory
NSW (2)
  • Researchers (1)
  • Funded Activities (2)
  • Organisations (0)
  • Funded Activity

    Linkage Projects - Grant ID: LP0347269

    Funder
    Australian Research Council
    Funding Amount
    $69,099.00
    Summary
    Mammalian chitinases and gene therapy: new weapons to combat fungal and insect attack in mammals. Plants combat fungal and insect attack by producing chitin degrading enzymes. Related, chitinolytic enzymes have been identified in mammals, but their functions are unclear. We found that chitinases from human macrophages inhibited fungal growth. We hypothesise that, like plants, mammalian chitinases are produced to fight chitin containing pathogens. We will transform cells with a chitotriosidase ge .... Mammalian chitinases and gene therapy: new weapons to combat fungal and insect attack in mammals. Plants combat fungal and insect attack by producing chitin degrading enzymes. Related, chitinolytic enzymes have been identified in mammals, but their functions are unclear. We found that chitinases from human macrophages inhibited fungal growth. We hypothesise that, like plants, mammalian chitinases are produced to fight chitin containing pathogens. We will transform cells with a chitotriosidase gene and encapsulate them, creating bioreactors secreting chitinases. Therapeutic effects will be tested by grafting bioreactors to mice inoculated with Aspergillus. The research is a new approach to fighting chitin containing pathogens, with potential applications from parasite infestations in livestock to fungal infections in humans.
    Read more Read less
    More information
    Funded Activity

    BioPolymer Fibres For Remodelling Mdx And Damaged Muscle

    Funder
    National Health and Medical Research Council
    Funding Amount
    $527,286.00
    Summary
    This project aims to generate new, smart polymers for use in re-building muscle that has degenerated due to disease and-or trauma damage. The merger of smart polymers with biologically based solutions and cells has great potential to improve outcomes of treatments of damaged muscle in diseases such as Muscular Dystrophy.
    More information

    Showing 1-2 of 2 Funded Activites

    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback